Combining Primary Specificity Screenings for Drug Discovery Targeting T-box Antiterminator RNA

Combining Primary Specificity Screenings for Drug Discovery Targeting T-box Antiterminator RNA

Bibliographic Details
Main Author:	Myers, Mason Thomas
Language:	English
Published:	Ohio University Honors Tutorial College / OhioLINK 2021
Subjects:	Biochemistry Chemistry RNA Drug Discovery T-box Riboswitch Computational Screening Fluorescence Ligand Binding
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ouhonors1619173211823351

Similar Items

Riboswitch Drug Discovery: Identification and Characterization of T Box Antiterminator RNA Ligands as Potential Antibacterial Agents
by: Zhou, Shu
Published: (2011)

Riboswitch-targeted Drug Discovery: Investigation of Factors that Affect the T Box Transcription Antitermination Mechanism
by: Zeng, Chunxi
Published: (2016)

Drug Discovery Studies of the T box Riboswitch: Potential Ligand Inhibition andCofactor Modulation of the tRNA-Antiterminator Complex Recognition
by: Schopis, Jia L.
Published: (2016)

Non-Conserved Residues in Clostridium acetobutylicum tRNAAla Contribute to tRNA Tuning for Efficient Antitermination of the alaS T Box Riboswitch
by: Liang-Chun Liu, et al.
Published: (2015-09-01)

Pharmacophore Model Development: Targeting Noncoding RNA for Antibacterial/Antiviral Drug Discovery
by: Aldhumani, Ali Hamed
Published: (2021)

Specific structural elements of the T-box riboswitch drive the two-step binding of the tRNA ligand
by: Jiacheng Zhang, et al.
Published: (2018-09-01)

Structural and Mechanistic Studies of the THI Box and S<sub>MK</sub> Box Riboswitches
by: Smith, Angela Mae
Published: (2009)

Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
by: Martina Maccesi, et al.
Published: (2019-10-01)

CHARACTERIZATION OF THE LYSINE-RESPONSIVE L BOX RIBOSWITCH
by: Mitchell, Sharnise Nicole
Published: (2012)

Analysis of Stem I elements required for antitermination of the T box riboswitch
by: Kreuzer, Kiel D.
Published: (2018)

Binding free energy decomposition and multiple unbinding paths of buried ligands in a PreQ1riboswitch
by: Hu, G., et al.
Published: (2021)

Fluorescent GFP chromophores as potential ligands for various nuclear receptors
by: Duraj-Thatte, Anna
Published: (2012)

Identification of Factors Involved in the Regulation of the <i>Bacillus subtilis metK</i> Gene
by: Allen, George M.
Published: (2016)

Ligand Binding Mechanism and Its Relationship with Conformational Changes in Adenine Riboswitch
by: Guodong Hu, et al.
Published: (2020-03-01)

Dynamic Docking: A Paradigm Shift in Computational Drug Discovery
by: Dario Gioia, et al.
Published: (2017-11-01)

High-throughput screening of cell-free riboswitches by fluorescence-activated droplet sorting
by: Tabuchi, T., et al.
Published: (2022)

Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery
by: Renjie Huang, et al.
Published: (2016-07-01)

Non-canonical T box riboswitch-tRNA recognition in <i>ileS</i> variants
by: Frandsen, Jane K.
Published: (2019)

Characterization of the metK and yitJ leader RNAs from the Bacillus subtilis S Box regulon
by: Pradhan, Vineeta A.
Published: (2012)

Native Mass Spectrometry in Fragment-Based Drug Discovery
by: Liliana Pedro, et al.
Published: (2016-07-01)

A Personal History of Using Crystals and Crystallography to Understand Biology and Advanced Drug Discovery
by: Tom L. Blundell
Published: (2020-08-01)

Effects of Metal Ions and Loop Stability on the Structure and Function of the T Box Antiterminator RNA and its complex with Model tRNA
by: Muchenditsi, Abigael M.
Published: (2009)

Characterization of the SMK box: A riboswitch that binds S-adenosylmethionine
by: Fuchs, Ryan T.
Published: (2009)

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
by: Javier Vázquez, et al.
Published: (2020-10-01)

Solution NMR Spectroscopy in Target-Based Drug Discovery
by: Yan Li, et al.
Published: (2017-08-01)

Yersinia pestis and Yersinia pseudotuberculosis infection: a regulatory RNA perspective
by: Viveka eVadyvaloo, et al.
Published: (2015-09-01)

The Serine Biosynthesis of <em>Paenibacillus polymyxa</em> WLY78 Is Regulated by the T-Box Riboswitch
by: Haowei Zhang, et al.
Published: (2021-03-01)

Tractable RNA–ligand interaction kinetics
by: Felix Kühnl, et al.
Published: (2017-10-01)

RNA elements required for T box antitermination /
by: Winkler, Wade C.
Published: (2002)

RNA elements required for T box antitermination
by: Winkler, Wade C.
Published: (2002)

Multiple chemical scaffolds inhibit a promising Leishmania drug target
by: Malcolm Walkinshaw
Published: (2014-07-01)

Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on<i> Balamuthia mandrillaris, Naegleria fowleri, </i>and<i> Acanthamoeba castellanii</i>
by: Christopher A. Rice, et al.
Published: (2020-06-01)

Membrane Sensor Histidine Kinases: Insights from Structural, Ligand and Inhibitor Studies of Full-Length Proteins and Signalling Domains for Antibiotic Discovery
by: Pikyee Ma, et al.
Published: (2021-08-01)

Molecular dynamics simulations and drug discovery
by: Durrant Jacob D, et al.
Published: (2011-10-01)

Ligand-macromolecule interactions
by: Wade, R. C.
Published: (1988)

Diphosphine Ligand Substitution in H4Ru4(CO)12: X-ray Diffraction Structures and Reactivity Studies of the Diphosphine Substituted Cluster Products
by: Kandala, Srikanth
Published: (2006)

Trying on tRNA for Size: RNase P and the T-box Riboswitch as Molecular Rulers
by: Jinwei Zhang, et al.
Published: (2016-04-01)

Structure and Function in Archaeal RNase P and the S<sub>MK</sub> Box Riboswitch
by: Wilson, Ross C.
Published: (2009)

Protein X-ray Crystallography and Drug Discovery
by: Laurent Maveyraud, et al.
Published: (2020-02-01)

Riboswitches as Drug Targets for Antibiotics
by: Vipul Panchal, et al.
Published: (2021-01-01)